EENERGY GROUP PLC (EAAS) — Research Note

Executive summary

eEnergy is a UK-listed Energy-as-a-Service installer that funds and delivers LED, solar PV, battery storage and EV charging for the education, NHS and C&I sectors on a "no upfront capex" model. Over 2020-2026 the Group pivoted from pure LED to multi-product via acquisitions, grew revenue from £4.5m (FY20) to a guided £32m (FY26), but suffered material accounting misstatements (FY23 disclaimer of opinion), repeated downgrades, project-documentation failures on its biggest contract (DofE/Mace), and in October 2026 ran out of working capital, forcing a £8.3m rescue placing at 0.3p — a 79% discount — that will issue 2.76bn new shares (≈88% of enlarged capital). The valuation debate today is almost entirely about dilution, going-concern risk and whether a post-raise £~10m EV business delivering ~£2.5m FY27 Adj EBITDA justifies even today's distressed price.

Fair value estimate

• Methodology: EV/forward Adj EBITDA (sanity-checked against post-raise book value), post-dilution.
• Key assumptions: (i) GM on 23 Oct 2026 passes resolutions — highly likely given alternative is administration; (ii) 2.755bn new shares issue, taking share count to ~3,142m; (iii) FY27 management guidance of £25m revenue / £2.5m Adj EBITDA is a stretch target (DofE retrofit tender upside excluded); apply 3–5x multiple reflecting low quality, high execution risk; (iv) net debt ~£2.5m shareholder loans less £4m working-capital proceeds net of £4m creditor paydown ≈ ~£2.5m net debt residual.
• Range: 3x £2.5m = £7.5m EV, less £2.5m debt = £5m equity → ~0.16p/share. 5x £2.5m = £12.5m EV, less £2.5m debt = £10m equity → ~0.32p/share.
• Fair value per share: 0.15p – 0.35p (post-dilution); implied market cap range: £5m – £11m on 3,142m enlarged share base 2026-10-02 placing announcement; 2026-04-30 FY25 results.
• Comparison to current £1.4m mcap (pre-raise, 387m shares): at 0.31p a buyer today who holds through the raise will suffer dilution to ~12.3% of enlarged capital; the 0.31p post-raise is roughly in the middle of my fair-value range, i.e. fairly valued at best, with asymmetric downside.
• Absolute upside/downside: on the mid-point ≈0.25p, downside ~20% from 0.31p. On enlarged market cap basis the share is in line with fair value, not cheap.

Sector context

Confirmed as ICB Industrial Goods and Services — Construction & Materials sub-sector functionally. Peer comparables: Luceco plc (LED/EV products — ironically eEnergy's product supplier and former ~9% holder, Main Market, far better financial quality); Everest Group (now private); the closer analogue is Redaptive (private US EaaS, eEnergy's funding partner). On every quality dimension — gross margin, cash conversion, balance-sheet strength, management continuity, earnings quality — eEnergy is materially below the typical UK industrial-services peer. It should trade at a steep discount to the sector.

Investment thesis (3 bullets)

1. Structural tailwind to UK decarbonisation of public estates is genuine: Group has frameworks (CCS, LASER, NHS Commercial Solutions), has delivered 1,200+ projects, and the Redaptive £100m funding partnership removes customer capex objections 2026-04-30 FY25 results. Post-raise balance sheet is clean enough to tender for larger contracts.
2. Recapitalisation + cost-out gives a credible 2027 base: £2m annualised cost savings from June 2026 restructuring (Board 6→3, SLT 10→5), £65m pipeline, FY27 guidance £25m revenue/£2.5m Adj EBITDA achievable even without the DofE retrofit tender 2026-10-02 trading & operational update.
3. Chairman and Harwood Capital underwriting the raise signals skin-in-the-game: Chairman John Samuel subscribed £50k personally, Harwood (12.3% holder) subscribed £1.5m and waived interest on its £2.5m loans 2026-10-02 placing; 2026-10-06 result of retail offer. This is at least an alignment of interests, if not a strong valuation signal.

Key risks (3 bullets)

1. Going-concern and governance history is awful: FY24 audit received a disclaimer of opinion from PKF Littlejohn after material project-accounting misstatements extending back to prior periods; revenue recognition policy was then changed again in April 2026 (restating £4m of FY25 revenue into FY26) 2025-06-30 FY24 final results; 2026-04-16 Q1 trading update. Repeated restatements, auditor change, and now a dilutive rescue — fool-me-twice territory.
2. No AI thesis whatsoever: Business is a decarbonisation installer for schools and hospitals. "AI" appears nowhere in the filings. Does not fit the investor's primary driver all filings reviewed.
3. Fragile capital structure persists post-raise: £2.5m shareholder loans from Harwood remain, £4m of the £8.3m proceeds immediately pays overdue creditors, and the business is still a working-capital-intensive installer dependent on third-party funders (Redaptive) for its "zero upfront" model. If Mace documentation delays persist or the next big contract has similar execution issues, this will be back to the market inside 12 months 2026-10-02 placing announcement.

Operating leverage

Modest, not high. FY26 blended gross margin guided to ~30% (FY25: 33.1%, H1-26 Adj EBITDA £1.2m on £21.8m revenue = 5.5% margin). The cost base is dominated by variable project costs, subcontract labour and commissions — not fixed R&D or platform infrastructure. Central costs are now only ~£2m post-restructuring, so there is some operating leverage: a 20% revenue beat vs the £25m FY27 base (i.e. £30m) at 30% blended GM would add ~£1.5m incremental gross profit against a fixed cost base of ~£5m operating costs excluding COGS → Adj EBITDA could rise from £2.5m to ~£4m (+60%). That is real but modest leverage — typical industrials territory, not SaaS. The DofE retrofit tender (£8m/yr for 3 years) is the one event that would create meaningful inflection, but it is unsecured. 2026-04-30 FY25 results; 2026-10-02 trading update

Value-trap signals

• Material accounting misstatements and auditor disclaimer of opinion in FY24.
• Three material revenue-recognition policy changes between FY24 and FY26.
• Dividend has never been paid; no path to one visible.
• Repeated profit-warnings and guidance downgrades (FY26 Adj EBITDA guided £4.5m in Jan 2026 → £1.7m by Jun 2026).
• Related-party dependence: Harwood (12.3% holder) is sole lender; Chairman participates in rescue placing requiring independent-director fair-and-reasonable opinion.
• Mace/DofE contract — the Group's "largest ever" — materially impaired cash collection due to the Group's own documentation failures (retrospective planning permission for 42 battery sites).
• Revenue growth has come partly from accounting policy, not underlying activity (FY25 restated revenue £19m vs originally guided £23m).
• Share price down 94% over 12 months, including >80% in last 30 days — the market is pricing permanent impairment risk, not temporary mispricing.

Earnings vs. expectations

Pattern: repeated misses and sequential downgrades, with revenue recognition policy changes serving as the mechanism to reconcile. This is a 20-39 "more misses than beats" track record.

Conviction

3 — moderate, biased slightly lower. Anchoring factors: (i) current share price is below reasonable fair-value under even optimistic post-dilution assumptions; (ii) the £8.3m raise is near-certain to pass; (iii) FY27 numbers are now plausible after the cost-out. Limiting factors: (i) accounting history is bad enough that I would not stake high conviction on any management-provided number without a clean post-raise audit cycle; (ii) share count expansion of 7x means per-share value is extraordinarily sensitive to the eventual outcome of the Mace receivable and the DofE retrofit tender — binary-ish outcomes that are hard to price.